POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION Monday, March 22, 2010   —  9:30 AM - 12:00 Noon Exhibit Hall Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... BREAST PATHOLOGY Poster# Title and Authors Itinerary Planner 12 Use of High Resolution Array Comparative Genomic Hybridization To Identify Mouse Double Minutes 4 as an Early Genetic Change in Breast Cancer Development: Evaluation of Mdm4 as a New Prognostic and Predictive Marker (127) TMA Abdel-Fatah, DG Powe, M Lambros, R Natrajan, A Green, JS Reis-Filho, IO Ellis - School of Molecular Medical Sciences and Nottingham University Hospitals Trust, University of Nottingham, Nottingham, United Kingdom; Institute of Cancer Research, London, United Kingdom Add 13 Are Histologically Benign Papillarly Lesions of the Breast Associated with Increased Risk for Developing In Situ or Invasive Carcinoma? A Follow Up Study of 302 Patients (145) H Arabi, S Bandyopadhyay, Z Nahleh, M Ibrahim, B Albashiti, Q Ahmed, W Sakr, R Ali-Fehmi - Emory University, Atlanta, GA; Wayne State University, Detroit, MI; Karmanos Cancer Institute, Detroit, MI Add 14 Endogenous Hormone Levels and Risk of Androgen Receptor Positive Breast Cancer: Results from the Nurses' Health Study (175) K Cole, J Marotti, R Hu, RM Tamimi, SE Hankinson, SJ Schnitt, LC Collins - Beth Israel Deaconess Medical Center, Boston; Brigham and Women's Hospital, Boston, MA Add 15 Breast Cancer Tumor Marker Profile: A Comparison of Clinical Laboratory Testing Methods (187) EK Drinka, N Wadhwani, A Bargaje, C Ersahin, A Salhadar, J Sinacose, P Rajan - Loyola University Medical Center, Chicago, IL Add 16 Amplification of the FGRF1 Gene and Its Relationship with Gene Expression and Clinical Significance in Breast Cancer (206) A Gru, AL Salavaggione, J Hoog, J Snyder, Y Tao, M Ellis, DC Allred - Washington University in St Louis, Saint Louis, MO Add 17 Comparative Analysis of Ki67 Expression and Its Association with Axillary Nodal Metastasis in Patients with Triple Negative Versus Non-Triple Negative Breast Carcinomas (210) JS Han, KH Molberg, VR Sarode, LM Sutton, Y Peng - The University of Texas Southwestern Medical Center, Dallas, TX Add 18 Estrogen Receptor-beta Expression in Normal Breast Tissue in Relation to Benign Breast Disease Category and Breast Cancer Risk: Results from the Nurses' Health Study (215) J Hilson, Y Wang, J Connolly, S Schnitt, L Collins, R Tamimi - Beth Israel Deaconess Medical Center, Boston, MA; Montefiore Medical Center, Bronx, NY; Channing Institute, Boston, MA Add 19 Glucose Transporter Glut-1 Expression Correlates with Basal-Like Breast Cancer (223) YR Hussein, S Bandyopadhyay, Q Ahmed, T Jazaerly, B Albashiti, M Ibrahim, Z Nahleh, W Sakr, R Ali-Fehmi - Wayne State University and Karmanos Cancer Institute, Detroit, MI Add 20 Combined Proteomic-Transcriptomic Profiling of Laser Capture Microdissected Normal and Breast Cancer Epithelium Reveals Systematic Biochemical Network Alterations (225) M Imielinski, S Cha, EA Richardson, D Thakur, T Rejtar, S-L Wu, B Karger, D Sgroi - Massachusetts General Hospital, Boston, MA; Northeastern University, Boston, MA Add 21 A Comparison of HER 2 Expression in Primary Breast Carcinomas vs Organs of Metastasis A Comprehensive Retrospective Review (232) DF Jones, DJ Dabbs, MQ Rosenzweig, M Chivukula - Magee Womens Hospital of UPMC, Pittsburgh, PA Add 22 Histologic and Immunophenotypic Comparison of Estrogen Receptor-Positive Breast Cancers in BRCA1 Mutation Carriers and Sporadic ER-Positive Breast Cancers: A Case-Control Study (235) J Kaplan, S Schnitt, L Collins, Y Wang, J Garber, K Montgomery, R West, N Tung - Beth Israel Deaconess Medical Center, Boston, MA; Dana Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Stanford University, Palo Alto, CA Add 23 Expression of Estrogen Receptor β Isoforms in Male and Female Breast Carcinoma (244) TS Kraus, D Lawson, C Cohen - Emory University, Atlanta, GA Add 24 Relationship between Molecular Subtype of Invasive Breast Carcinoma and Expression of Gross Cystic Disease Fluid Protein 15, Mammaglobin, and Androgen Receptor (252) GH Lewis, AP Subhawong, H Nassar, R Vang, J Hicks, A De Marzo, BH Park, P Argani - Johns Hopkins Medical Institutions, Baltimore, MD Add 25 Prognostic Value of Multiple Triple-Negative Markers in Breast Cancer (261) S Lu, O Walter, P Vohra, D Kandil, LJ Wang, AM Mercurio, A Khan - Warren Alpert Medical School at Brown University, Providence, RI; University of Massachusetts Medical School, Worcester, MA Add 26 Triple Positive Breast Carcinomas: Is Onco Type Dx™ Test Justified? (265) E Marchetti, R Bhargava, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA Add 27 Pathologic Features and Distribution of Molecular Phenotype Among Young Women with Breast Cancer: Results from the Young Women's Breast Cancer Study (266) JD Marotti, LC Collins, S Gelber, K Ruddy, S Kereakoglow, EF Brachtel, E Winer, A Partridge - Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute and Massachusetts General Hospital, Boston, MA Add 28 FOXA1 Is a Prognostic Marker in Breast Cancer - A Validation Study of 4046 Cases (268) R Mehta, RK Jain, TO Nielsen, S Leung, J Choo, H Nakshatri, D Hunstman, S Badve - Indiana University, Indianapolis; University of British Columbia, Vancouver, Canada Add 29 Human Epidermal Growth Factor Receptor 2 Status Determination Using Single Color Versus Dual Color Fluorescence In-Situ Hybridization Assay: Impact of Monosomy and Polysomy 17 (275) LA Niemeier, D Dabbs, U Surti, K Cieply, J Yu, R Bhargava - University of Pittsburgh, Pittsburgh, PA Add 30 Response to Trastuzumab-Based Neoadjuvant Therapy Does Not Correlate with Level of HER2 Amplification While Deletion of Chromosome 17 May Predict a Poor Pathologic Response (288) B Quigley, G Acs, P McNab, J Shutter, H Soliman, J Kiluk, NN Esposito - H Lee Moffitt Cancer Center and University of South Florida, Tampa, FL Add 31 Upgrade Rates of Lobular Neoplasia on Core Needle Biopsy: Should Atypical Lobular Hyperplasia Be Routinely Excised? (295) MH Rendi, SM Dintzis, PR Eby, KE Calhoun, KH Allison - Univ of Washington, Seattle, WA Add 32 Most Salivary Gland-Like Tumors of Breast Express Basal Type Immunohistochemical Markers (296) C Reyes, M Jorda, A Mejias, C Gomez-Fernandez - University of Miami Jackson Memorial Hospital and Sylvester Comprehensive Cancer Center, Miami, FL Add 33 Thyroid Transcription Factor (TTF-1) Expression in Breast Carcinomas (298) JN Robens, LC Goldstein, AM Gown, SJ Schnitt - Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; PhenoPath Laboratories, Seattle, WA Add 34 Intratumoral Heterogeneity of HER-2/Neu Gene Amplification in Breast Cancer (309) H Seol, HE Lee, SW Kim, JH Kim, G Choe, SY Park - Seoul National University Bundang Hospital, Seongnam, Korea Add 35 MYC Gene Amplification in Breast Cancer Metastases Relative to Matched Primary Tumors (317) AD Singhi, RB Jenkins, F Lin, S Fink, H Nassar, R Vang, A De Marzo, P Argani - The Johns Hopkins Medical Institutions, Baltimore, MD; Mayo Clinic, Rochester, MN Add 36 Lipocalin-2/NGAL Expression Is Associated with Clinical Outcome in Invasive Mammary Carcinoma (318) EA Slodkowska, D Cho, AB Boguniewicz, CB Sheehan, CE Sheehan, JS Ross - Albany Medical College, Albany, NY Add 37 Degree of Intratumoral EGFR and Cytokeratin 5/6 Expression Is Significantly Associated with Nodal and Distant Metastases in Patients with Basal-Like Triple-Negative Breast Carcinoma (323) LM Sutton, KH Molberg, VR Sarode, JS Han, J Sailors, Y Peng - UT Southwestern, Dallas, TX Add 38 Biological Intrinsic Classification of Breast Cancer by Immunohistochemistry and qPCR Using Blocks from the NCIC MA12 Trial (330) K Ung, SK Chia, M Cheang, CM Perou, PS Bernard, L Sheperd, TO Nielsen - University of British Columiba, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada; University of North Carolina at Chapel Hill, Chapel Hill, NC; University of Utah Health Science Center, Salt Lake City, UT; NCIC Clinical Trials Group, Kingston, ON, Canada Add 39 Sentinel Node Biopsy in Early Breast Cancer: Does Tumor Burden in Sentinel Node Predict the Number of Positive Axillary Nodes? (334) NR Wadhwani, EK Drinka, T Baker, G Aranha, C Ersahin, J Sinacore, E Rajan, A Salhadar, P Rajan - Loyola University Medical Center, Maywood, IL; University of East Anglia, Norwich, England, United Kingdom Add 40 Fibroblast-Like Stromal Response Is Host-Dependent While Macrophage-Associated Stromal Response Is Tumor-Dependent: A Study of Stromal Response in Paired Breast Carcinomas from Patients with Dual Primaries (346) JM Wu, AH Beck, D Witten, K Allison, M van de Rijn, RB West - Stanford Unversity Medical Center, Palo Alto, CA; University of Washington Medical Center, Seattle, WA Add